Vertex Pharmaceuticals Q3 2022 Earnings Preview
Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce Q3 earnings results on Thursday, October 27th, after market close.
The consensus EPS Estimate is $3.64 (+2.2% Y/Y) and the consensus Revenue Estimate is $2.23B (+12.6% Y/Y).
Over the last 2 years, VRTX has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 13 upward revisions and 7 downward. Revenue estimates have seen 19 upward revisions  and 1 downward.